🔎 Trials Near Me

Home › Mantle Cell Lymphoma › Michigan

Mantle Cell Lymphoma clinical trials in Michigan

9 studies for Mantle Cell Lymphoma are looking for participants at sites in Michigan.

Cities in Michigan

A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )

  • University of Michigan Comprehensive Cancer Center, Ann Arbor
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Nov 4, 2026 · NCT07101328

Testing Continuous Versus Intermittent Treatment With the Study Drug Zanubrutinib for Older Patients With Previously Untreated Mantle Cell Lymphoma

  • Trinity Health Saint Joseph Mercy Hospital Ann Arbor, Ann Arbor
  • McLaren Cancer Institute-Bay City, Bay City
  • Trinity Health IHA Medical Group Hematology Oncology - Brighton, Brighton
  • and 26 more
RecruitingPhase 3
Ages 60 and older · All sexes · Updated Nov 3, 2026 · NCT05976763

A Study to Investigate the Efficacy and Safety of Sonrotoclax Plus Zanubrutinib Compared With Placebo Plus Zanubrutinib in Adults With Relapsed/Refractory Mantle Cell Lymphoma (CELESTIAL-RRMCL)

  • University of Michigan, Ann Arbor
  • The Cancer and Hematology Centers, Grand Rapids
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Oct 29, 2026 · NCT06742996

Natalizumab for the Prevention of ICANS in Patients With Recurrent or Refractory Diffuse Large B-Cell Lymphoma or Mantle Cell Lymphoma Receiving CAR T-Cell Therapy

  • University of Michigan Rogel Cancer Center, Ann Arbor
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Oct 23, 2026 · NCT07892027

A Study of APG-3288 in Relapsed/Refractory Blood Cancers

  • START Midwest, Grand Rapids
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Oct 15, 2026 · NCT07424833

Venetoclax, Lenalidomide and Rituximab in Patients With Previously Untreated Mantle Cell Lymphoma

  • University of Michigan, Ann Arbor
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Oct 14, 2026 · NCT03523975

A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies

  • Karmanos Cancer Institute, Detroit
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Oct 5, 2026 · NCT05006716

DALY II USA/ MB-CART2019.1 for DLBCL

  • University of Michigan, Ann Arbor
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Jul 13, 2026 · NCT04792489

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

  • Massive Bio SYNERGY-AI site, Ann Arbor
  • Massive Bio SYNERGY-AI site, Lansing
RecruitingObservational study
All ages · All sexes · Updated Oct 28, 2025 · NCT03452774

From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.